Business Unit, Executive Director, HCV and Liver Disease, Gilead France @ Gilead Sciences
Senior Director, Market Access and Reimbursement, Gilead France @ Gilead Sciences
Manager Market Access - New Product Planning @ Eli Lilly
Associate Pricing, Reimbursement and Access @ Eli Lilly
Jonathan Pentel's Education
ESCP Europe
Executive MBA
2016 - 2017
Medical Doctor - University Pierre et Marie Curie Paris VI
Medical Doctor (Public Health Physician)
1995 - 2006
Cornell University
Executive Education (Leading innovation)
2017 - 2017
Shanghai Jiao Tong University
ANTAI Business School Executive education (Leading for innovation in China)
2016 - 2016
Université Paris Sud (Paris XI)
Master (Epidemiology & Clinical Research)
2005 - 2006
Université René Descartes (Paris V)
University Degree (Pharmacoeconomics)
2004 - 2005
Pierre and Marie Curie University
Medical Doctor (Public Health)
Université Pierre et Marie Curie
Doctor of Medicine - MD
ESCP Business School
Executive MBA (Business Administration and Management, General)
2016 - 2017
Jonathan Pentel's Skills
Market Access
Health Economics
HTA
Pricing
Outcomes Research
Strategy
Pharmacoeconomics
Epidemiology
Pharmaceutical Industry
Oncology
Jonathan Pentel's Summary
Jonathan Pentel, based in Paris, FR, is currently a Country Medical Director, Janssen France at The Janssen Pharmaceutical Companies of Johnson & Johnson, bringing experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences. Jonathan Pentel holds a 2016 - 2017 Executive MBA @ ESCP Europe. With a robust skill set that includes Market Access, Health Economics, HTA, Pricing, Outcomes Research and more, Jonathan Pentel contributes valuable insights to the industry. Jonathan Pentel has 3 emails on RocketReach.